(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VALUECENTRIC

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

VALUECENTRIC

ST13

US500000078669172

Class

35, 42

Filing

78669172

Registration

3198200

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

01/17/2026

Trademark type

Word

Nice classes

35, 42

Filing date

07/13/2005

Registration date

01/16/2007

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/23/2016

Last transaction

01/17/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

08/01/2002

First use in commerce

08/01/2002

Drawing code

4

Owner type

03

Owner location

PARSIPPANY, NJ

Examiner

THOMAS JR, RAY

Law office

L20

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

IQVIA INC.
Valuecentric, LLC

Representatives

Cynthia Johnson Walden Fish & Richardson P.C.

Technical classification

Nice Classes

Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Providing customer specific business information relating to the distribution of pharmaceutical products for use by pharmaceutical manufacturersdistributorswholesalers and retailers; and business consulting services in the pharmaceutical industry

Class 42

Providingthrough non-downloadable web-based computer softwareelectronic data management and configuration services in the pharmaceutical industryproviding customer specific product information relating to the distribution of pharmaceutical products for use by pharmaceutical manufacturersdistributorswholesalers and retailers; and consulting services in the field of pharmaceutical products

Publications

History of USPTO decisions and trademark events.

29 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/16/2026

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/22/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/13/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/13/2019

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

07/24/2016

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

07/23/2016

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/23/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/23/2016

E89R

TEAS SECTION 8 & 9 RECEIVED

05/04/2016

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED

07/13/2012

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

07/13/2012

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/02/2012

E815

TEAS SECTION 8 & 15 RECEIVED

06/28/2012

R.PR

REGISTERED-PRINCIPAL REGISTER

01/16/2007

PUBO

PUBLISHED FOR OPPOSITION

10/31/2006

NPUB

NOTICE OF PUBLICATION

10/11/2006

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

09/16/2006

ALIE

ASSIGNED TO LIE

09/08/2006

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/05/2006

CNEA

EXAMINERS AMENDMENT MAILED

08/28/2006

XAEC

EXAMINER'S AMENDMENT ENTERED

08/28/2006

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/28/2006

ACEC

AMENDMENT FROM APPLICANT ENTERED

08/04/2006

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/27/2006

MAIL

PAPER RECEIVED

07/27/2006

CPRA

PRIORITY ACTION MAILED

02/13/2006

CPRA

PRIORITY ACTION WRITTEN

02/13/2006

DOCK

ASSIGNED TO EXAMINER

02/02/2006

NWAP

NEW APPLICATION ENTERED

07/19/2005

Continuous trademark protection

Get notified about every new filing that threatens VALUECENTRIC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.